“Aspen Capital has proven to be an outstanding partner for CLARA. Their operational and investment expertise has been instrumental in refining our go-to-market strategy. The Aspen team also connected us with key insurance prospects and channel partners, which played a major role in boosting our business development efforts and led to significant revenue opportunities. I am delighted to have Aspen as a partner.”

Acquired by SailPoint (NYSE: SAIL)

“Since making their first investment, Aspen has provided immeasurable support to ERP Maestro. Aspen was engaged in assessing nearly every aspect of the business. They quickly recognized where we needed support and without being overbearing they provided helpful assistance to the Company. They helped us put the scaffolding in place to scale and professionalize the organization and continued to push our thinking to help us get clarity around key strategic decisions. When working with a strategic partner, integrity is very important to us and they did everything they said they would do, and we are thrilled with our partnership. They played a key role in in creating value alongside management which lead to our ultimate sale to SailPoint.”

“Steve Jones of Aspen Capital was instrumental in the growth and development of NeoGenomics. Aspen closed its first investment in 2003 and continued to invest for years as the Company required growth capital. In addition, Steve was deeply involved in helping NeoGenomics refine its business model and strategy, and execute many strategic initiatives. Today, NeoGenomics is a recognized leader in Oncology Diagnostics with a market capitalization over $5 billion and Steve remains a trusted member of our Board.”